Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988; 334: 519–522.
Mahomed AG, Murray J, Klempman S, et al. Pneumocystis carinii pneumonia in HIV infected patients from South Africa. East Afr Med J 1999; 76: 80–84.
McLeod DT, Neill P, Robertson VJ, et al, Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans R Soc Trop Med Hyg 1989; 83: 694–697.
Singh VR, Smith DK, Lawerence J, Kelly PC, Thomas AR, Spitz B, Sarosi GA., Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution. Clin Infect Dis 1996; 23: 563–568.
Tesh RB, Schneidau JD. Primary cutaneous histoplasmosis. N Engl J Med 1966; 275:597–599
Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol 2000; 38(Suppl 1): 269–279.
Matee MI, Matre R. Pathogenic isolates in meningitis patients in Dar Es Salaam, Tanzania. East Afr Med J 2001; 78: 458–460.
Bergemann A, Karstaedt AS. The spectrum of meningitis in a population with high prevalence of HIV disease. Q J Med 1996; 89: 499–504.
Hakim JG, Gangaidzo IT, Heyderman RS, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 2000; 14: 1401–1407.
Bogaerts J, Rouvroy D, Taelman H, Kagame A, Aziz MA, Swinne D, Verhaegen J. AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features. J Infect 1999; 39: 32–37.
French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002; 16: 1031–1038.
Karstaedt AS, Crewe-Brown HH, Dromer F. Cryptococcal meningitis caused by Cryptococcus neoformans var gatii, serotype C, in AIDS patients in Soweto, South Africa. Med Mycol 2002; 40: 7–11.
Aberg JA, Powderly WG. Cryptococcosis. Adv Pharmacol 1997; 37: 215–251.
Moosa MY, Coovadia YM.; Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HlV)-positive and HIV-negative patients. Clin Infect Dis 1997; 24: 131–134.
Gumbo T, Kadzirange G, Mielke J, Gangaidzo IT, Hakim JG. Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2002; 21: 54–56.
Mundy LM, Powderly WG. Invasive fungal infections: Cryptococcosis. Seminars in Respiratory and Critical Care Medicine 1997; 18: 249–257.
Batungwanayo J, Taelman H, Lucas S, et al. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit CareMed 1994; 149: 1591–1596.
Aberg JA, Mundy LM, Powderly WG. Pulmonary cryptococcosis in patients without HIV infection. Chest 1999; 115: 734–740.
van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 1997; 337: 15–21.
Ennis DM, Saag MS. Cryptococcal meningitis in AIDS. Hosp Pract (Off Ed) 1993; 28: 99–102, 105–107, 111–112.
Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991; 91: 267–272.
White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992; 165: 960–963.
Aberg JA. Reconstitution of immunity against opportunistic infections in the era of potent antiretro viral therapy. AIDS Clin Rev, 2000-01: 115–138.
Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 710–718.
Fagon JY, Novara A, Stephan F, Girou E, Safar M. Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol 1994; 15: 428–434.
Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598–1601.
Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–1530.
Meunier F. Systemic candidal infections in neonates. Clin Infect Dis 1992; 15: 554.
Wingard JR Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115–125.
Fraser VJ, Jones M, Dunkel J, et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414–421.
Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 1989; 64: 2030–2034.
van de Wetering MD, Poole J, Friedland I, Caron HN. Bacteraemia in a paediatric oncology unit in South Africa. Med Pediatr Oncol 2001 37: 525–531.
Schwartz RS, Mackintosh FR, Halpern J, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia. Cancer 1984; 54: 1672–1681.
Bodey GP. Candidiasis: Pathogenesis, diagnosis and treatment. New York: Raven Press, 1992.
Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875–883.
Smith C, Arregui LM, Promnitz DA, Feldman C. Septic shock in the Intensive Care Unit, Hillbrow Hospital, Johannesburg. S Afr Med J 1991; 80:181–184.
Bodey GP. The emergence of fungi as major hospital pathogens. J Hosp Infect 1988; 11(Suppl A): 411–426.
Buff SJ, McLelland R, Gallis HA, Matthay R, Putman CE. Candida albicans pneumonia: radiographic appearance. AJR 1982; 138: 645–648.
Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987; 9:1006–1012.
Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000; 19: 319–324.
Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121:1988–1999.
Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983; 38: 572–578.
Oren I, Goldstein N. Invasive pulmonary aspergillosis. Curr Opin Pulm Med 2002; 8:195–200.
Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147–1201.
Kallenbach J, Dusheiko J, Block CS, Bethlehem B, Koornhof HJ, Zwi S. Aspergillus pneumonia—a cluster of four cases in an intensive care unit. S Afr Med J 1977; 52: 919–923
Benatar SR. Aspergillus infection in the Western Cape. S Afr Med J 1977; 51: 297–305.
Shirakusa T, Ueda H, Saito T, Matsuba K, Kouno J, Hirota N. Surgical treatment of pulmonary aspergilloma and Aspergillus empyema, Ann Thorac Surg 1989; 48: 779–782.
Houston S. Histoplasmosis and pulmonary involvement in the tropics. Thorax 1994; 49: 598–601.
Bradsher RW. Histoplamosis. Seminars in Respiratory and Critical Care Medicine 1997; 18:3: 259–264
Craven SA, Benatar SR. Histoplasmosis in the Cape Province. A report of the second known outbreak. S Afr Med J 1979; 55: 89–92.
Valdez H, Salata RA. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med 1999; 6: 258–260.
Khalil MA, Hassan AW, Gugnani HC. African histoplasmosis: report of four cases from north-eastern Nigeria. Mycoses 1998; 41: 293–295.
Wheat LJ, Goldman M, Sarosi G. State-of-the-art review of pulmonary fungal infections. Semin Respir Infect 2002; 17: 158–181.
Goldman M, Johnson PC, Sarosi GA. Fungal pneumonias. The endemic mycoses. Clin Chest Med 1999; 20: 507–519.
Rippon, J.W. Medical Mycology, the pathogenic fungi and the pathogenic actinomycetes. 3rd ed. Philadelphia, PA: WB Saunders Company, 1988.
McKinsey DS. Histoplasmosis in AIDS: advances in management. AIDS Patient Care STDS 1998; 12: 775–781.
Stevens DA. Diagnosis of fungal infections: current status. J Antimicrob Chemother 2002; 49(Suppl 1): 11–19.
Sarosi GA, Johnson PC. Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1992; 14(Suppl 1): S60–S67.
Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30:688–695.
Feldman BS, Snyder LS. Primary pulmonary coccidioidomycosis. Semin Respir Infect 2001; 16: 231–237.
Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg 1996; 55:1–11.
Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999; 1:247–261.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Francois Venter, W.D., Sanne, I.M. (2005). Fungal infections in the ICU. In: Feldman, C., Sarosi, G.A. (eds) Tropical and Parasitic Infections in the Intensive Care Unit. Perspective on Critical Care Infectious Diseases, vol 9. Springer, Boston, MA. https://doi.org/10.1007/0-387-23380-6_11
Download citation
DOI: https://doi.org/10.1007/0-387-23380-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23379-6
Online ISBN: 978-0-387-23380-2
eBook Packages: MedicineMedicine (R0)